1.
Zh Nevrol Psikhiatr Im S S Korsakova
; Suppl 15: 13-27, 2005.
Artigo
em Russo
| MEDLINE
| ID: mdl-16447549
RESUMO
The benefits and limitations of intravenous thrombolytic therapy using recombinant tissue plasminogen activator (alteplase) are discussed. Pathophysiological background of thrombolysis, its history and ways of clinical usage, the major clinical trials, assessing safety and efficacy of the method, and practical recommendations, are presented.